NCT00019786 2012-03-23Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver MetastasesNational Institutes of Health Clinical Center (CC)Phase 2 Completed67 enrolled